This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
Menu
Follow UroToday
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mCRPC Treatment
          Charles Ryan, MD
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Neal Shore, MD, FACS
        • A Patient Journey
          Alicia Morgans, MD, MPH
          Charles J. Ryan, MD
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
  • Transformative Evidence
    • mCRPC
      • CARD Trial
      • PROfound Study
    • mHSPC
      • ENZAMET Trial
    • nmCRPC
      • PROSPER Trial
    • Advanced Prostate Cancer
      • HERO Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Videos
    • Conference Coverage and Experts Group
      • Interviews with Experts at Conferences
        • ASCO GU 2021 Bladder and Kidney Cancer
        • ASCO GU 2021 Prostate Cancer
        • ASCO 2019
        • ASCO 2020
        • ASCO GU 2020
        • ESMO 2020
      • Exclusive Collaborations
        • APCCC 2019
        • LUGPA Annual Meeting 2019
        • PCF 2019
        • SNMMI Curriculum
    • UroToday Exclusives
      • A Step Towards Personalized Medicine: PSMA PET Imaging in Prostate Cancer
      • Book Club
      • Clinical Trials in Progress
      • Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer
      • COVID-19 and Genitourinary Cancers Videos
      • Journal Club
      • Large Urology Group Practice Association (LUGPA)
      • Precision Medicine: PSMA Targeted Therapies in Progressive Metastatic Prostate Cancer Videos
    • Urologic Oncology
      • Prostate Cancer
        • Advances in Nuclear Medicine, PET, and Theranostics
        • Advanced Prostate Cancer
        • Cardiovascular Disease in Men with Prostate Cancer
        • CRPC with Bone Metastases
        • The Expert Voice
        • Imaging: Prostate Cancer
        • Localized Prostate Cancer
        • mCRPC
        • mHSPC
        • Molecular Diagnostics
        • Navigating Cancer
        • nmCRPC
        • The Patient Voice
        • Precision Medicine in Prostate Cancer
        • Prostate Cancer
      • Right Group
        • Bladder Cancer
          • Bladder Cancer
          • Bladder Cancer Expert Debates
          • Advanced Bladder Cancer
          • Non-Muscle Invasive Bladder Cancer
        • Kidney Cancer
          • Advanced Kidney Cancer
          • Renal Cancer
        • Upper Tract Urothelial Tumors
          • Upper Tract Urothelial Carcinoma
        • Pelvic Health & Reconstruction
          • Bladder Health
          • Indwelling Catheters
          • Intermittent Catheters
          • Nocturia & Lower Urinary Tract Conditions
        • Endourology
          • Endourology Today
          • Endourology
  • Journals
    • Everyday Urology - Oncology Insights
      Everyday Urology - Oncology Insights
      • From the Editor
      • Current Issue
      • Previous Issues
    • Prostate Cancer and Prostatic Diseases
      Prostate Cancer and Prostatic Diseases
      • From the Editor
      • Current Article
      • Previous Articles
  • Clinical Trials
    • Clinical Trials
      • Search Clinical Trials
    • From the Editor
      • Current Letter
      • Previous Letters
  • Conference Coverage
    • Advanced Prostate Cancer Consensus Conference (APCCC)
      • 2019 APCCC Meeting
    • American Society of Clinical Oncology (ASCO)
      • 2021 ASCO GU Symposium
      • 2020 Virtual Education Program
      • 2020 Annual Meeting
      • 2020 ASCO GU Symposium
    • American Urological Association (AUA)
      • 2020 Annual Meeting
    • ANZUP Mini Annual Scientific Meeting (ASM)
      • 2020 Virtual Annual Meeting
    • Bladder Cancer Advocacy Network (BCAN)
      • 2020 Think Tank Virtual Program
    • EAU Section of Oncological Urology
      • ESOU 2021
    • EMUC
      • 2020 Annual Meeting
    • European Association of Urology (EAU)
      • 2020 Annual Congress
    • European Society for Medical Oncology (ESMO)
      • 2020 Virtual Congress
    • Global Society of Rare GU Tumors
      • 2020 Meeting
    • International Bladder Cancer Network (IBCN)
      • 2020 Annual Virtual Meeting
    • NMIBC - Drug Development 2021
      • 2021 Annual Meeting
    • Prostate Cancer Academy
      • 2020 Annual Meeting
    • Société Internationale d'Urologie (SIU)
      • 2020 Annual Congress
    • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
      • 2020 Congress
    • Society of Urologic Oncology (SUO)
      • 2020 Annual Meeting
      • 2020 SUO - AUA Summer Webcast
    • Targeted Alpha Therapy (TAT)
      • 2019 Symposium
  • Articles
    • Urologic Oncology
      • Adrenal Diseases
      • Bladder Cancer
      • CRPC w/ Bone Metastases
      • Penile Cancer
      • Prostate Cancer
      • Renal Cancer
      • Testicular Cancer
      • Upper Tract Tumors
      • Investigative Urology
    • Men's Health
      • Androgen Deficiency
      • BPH
      • Erectile Dysfunction
      • Male Infertility
      • Peyronie’s Disease
      • Prostatitis
      • Vasectomy
    • Pelvic Health & Reconstruction
      • Fecal Incontinence
      • Fistula
      • GU Trauma & Reconstruction
      • Indwelling Catheters
      • Infections
      • Intermittent Catheters
      • Interstitial Cystitis
      • Neurogenic Bladder
      • Nocturia
      • Overactive Bladder
      • Pelvic Prolapse
      • Post-prostatectomy Incontinence
      • Stress Incontinence
      • Underactive Bladder
      • Urethral Strictures
      • Urinary Incontinence
      • Urinary Retention
      • Urinary Tract Infection – CAUTIs
      • Urologic Catheters
    • Endourology & Urolithiasis
      • Minimally Invasive Procedures
      • Stone Disease
    • Pediatric Urology
      • Pediatric Urology
    • COVID-19 and Genitourinary Cancers
      • COVID-19 and Genitourinary Cancers
  • Calendar
  1. UroToday Home
  2. Beyond the Abstracts
  3. Urologic Oncology

Renal Cancer

Beyond the Abstracts
Ampullary tumor caused by metastatic renal cell carcinoma, "Beyond the Abstract," by Jiaobo Zhai, MD October 24, 2014
The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma, "Beyond the Abstract," by Sandy Giuliano, Mélanie Guyot, Renaud Grepin, and Gilles Pages October 10, 2014
Efficacy of everolimus in patients with advanced renal cell carcinoma refractory or intolerant to VEGFR-TKIs and safety compared with prior VEGFR-TKI treatment, "Beyond the Abstract," by Renpei Kato, MD August 26, 2014
Two successful cases of the treatment of transitional cell carcinoma involving the renal pelvis in either a functional or anatomical solitary kidney, "Beyond the Abstract," by Bo Yang August 7, 2014
Chemotherapy-mediated p53-dependent DNA damage response in clear cell renal cell carcinoma: Role of the mTORC1/2 and hypoxia-inducible factor pathways, "Beyond the Abstract," by Veronica A. Carroll, PhD July 25, 2014
Adequate immunosuppression and oncological control employing temsirolimus as a base immunosuppressant for a recipient with metastatic renal cancer, "Beyond the Abstract," by Shih-Chieh Jeff Chueh, MD, PhD July 24, 2014
A 10-year, single institution review of renal cell carcinoma with venous neoplastic thrombosis, "Beyond the Abstract," by Giacomo Maria Pirola, MD July 22, 2014
The influence of different tumor enhancement measurement approaches on pretreatment differentiation, by CT, of renal cell carcinoma subtypes, "Beyond the Abstract," by Ivan Žokalj July 12, 2014
A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma, "Beyond the Abstract," by Denis L. Fontes Jardim and David S. Hong June 26, 2014
Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma, "Beyond the Abstract," by Ron Rodriguez, MD, PhD with Christos Georgiades, MD, PhD June 24, 2014
The association between statin medication and progression after surgery for localized renal cell carcinoma, "Beyond the Abstract," by Robert J. Hamilton, MD, MPH, FRCSC June 23, 2014
Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis, "Beyond the Abstract," by Adam Shrewsberry, MD June 20, 2014
A review of the current role of targeted therapy in the treatment of metastatic renal carcinoma, "Beyond the Abstract," by Paulo Jaworski, MD June 17, 2014
Washington University long-term experience with renal cryoablation versus robot-assisted partial nephrectomy, "Beyond the Abstract," by Eric H. Kim, MD June 11, 2014
Renal cancer-selective englerin A induces multiple mechanisms of cell death and autophagy, "Beyond the Abstract," by Ayse Batova, PhD June 6, 2014
A Malaysian single centre perspective of clinical prognostic factors and survival outcome in renal cell carcinoma patients, "Beyond the Abstract," by Ning Yi Yap May 16, 2014
Management of renal cell carcinoma with level I tumor thrombi using a combined retroperitoneoscopic and transperitoneal laparoscopic technique, "Beyond the Abstract," by Oner Sanli and Abubekir Boguk May 14, 2014
A case of bilateral renal cell carcinoma associated with long-term dialysis showing false-positive immunoreactivity for TFE3 as Xp11 translocation renal cell carcinoma, "Beyond the Abstract," by Aiko Kurisaki-Arakawa and Tsuyoshi Saito May 9, 2014
Kidney injury molecule-1 (KIM-1) may become a kidney “prostate specific antigen (PSA)” for renal cell carcinoma, "Beyond the Abstract," by Ping L. Zhang, MD, PhD, FCAP, FASN and Jason M. Hafron, MD April 12, 2014
Sunitinib-treated patients with renal cell carcinoma and benign prostatic hyperplasia expereince shrinkage of prostate volume, "Beyond the Abstract," by Takashi Hatano, MD, PhD March 31, 2014
Page 7 of 11
  • Start
  • Prev
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next
  • End
  • About UroToday
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use

COPYRIGHT © 2002 - 2021 DIGITAL SCIENCE PRESS, INC.

Follow UroToday

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free